Zykadia and Pain exacerbated - a phase IV clinical study of FDA data

Among these 29 people:

How long have people been on Zykadia when they have Pain exacerbated? *

• < 1 month: 33.33 %
• 1 - 6 months: 33.33 %
• 6 - 12 months: 0.0 %
• 1 - 2 years: 33.33 %
• 2 - 5 years: 0.0 %
• 5 - 10 years: 0.0 %
• 10+ years: 0.0 %

What is the gender of people who have Pain exacerbated when taking Zykadia? *

• female: 81.48 %
• male: 18.52 %

What is the age of people who have Pain exacerbated when taking Zykadia? *

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 0.0 %
• 30-39: 10.53 %
• 40-49: 21.05 %
• 50-59: 26.32 %
• 60+: 42.11 %

What are other drugs people take besides Zykadia? *

1. Calcium: 3 people, 10.34%
2. Vitamin B12: 2 people, 6.90%
3. Percocet: 2 people, 6.90%
4. Pepcid: 2 people, 6.90%
5. Lasix: 2 people, 6.90%
6. Keppra: 2 people, 6.90%
7. Imodium A-D: 2 people, 6.90%
8. Aleve: 2 people, 6.90%
9. Advil: 2 people, 6.90%
10. Xalkori: 1 person, 3.45%

What are other side effects people have besides Pain exacerbated? *

1. Nausea (feeling of having an urge to vomit): 14 people, 48.28%
2. Diarrhea: 10 people, 34.48%
3. Fatigue (feeling of tiredness): 9 people, 31.03%
4. Malignant Neoplasm Progression (cancer tumour came back): 7 people, 24.14%
5. Nausea And Vomiting: 5 people, 17.24%
6. Lung Neoplasm Malignant (cancer tumour of lung): 5 people, 17.24%
7. Metastases To Bone (cancer spreads to bone): 5 people, 17.24%
8. Dyspnea (difficult or laboured breathing): 5 people, 17.24%
9. Pleural Effusion (water on the lungs): 4 people, 13.79%
10. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 13.79%

What are the existing conditions these people have? *

1. Lung Neoplasm Malignant (cancer tumour of lung): 12 people, 41.38%
2. Lung Cancer - Non-Small Cell (lung cancer): 9 people, 31.03%
3. Arterial Insufficiency (lack of enough blood flow through the arteries): 3 people, 10.34%
4. Lung Adenocarcinoma (a form of non-small cell lung cancer): 2 people, 6.90%
5. Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 1 person, 3.45%
6. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 1 person, 3.45%
7. Metastases To Lung (cancer spreads to lung): 1 person, 3.45%
8. Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 1 person, 3.45%
9. Lung Carcinoma Cell Type Unspecified Recurrent (lung cancer reoccurrence): 1 person, 3.45%
10. Bronchial Carcinoma (lung cancer): 1 person, 3.45%

Do you take Zykadia and have Pain exacerbated?

- Check whether Pain exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

---

---

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zykadia:

Pain exacerbated treatments and more:

How severe was Pain exacerbated and when was it recovered:

• Pain exacerbated in Zykadia

Expand to all the drugs that have ingredients of ceritinib:

• Pain exacerbated and drugs with ingredients of ceritinib

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zykadia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

---

How the study uses the data?

The study uses data from the FDA. It is based on ceritinib (the active ingredients of Zykadia) and Zykadia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

---

---

Recent studies on eHealthMe:

No recent updates.